Autoimmune polyendocrine syndrome classification
Autoimmune polyendocrine syndrome Microchapters |
Differentiating Autoimmune polyendocrine syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Autoimmune polyendocrine syndrome classification On the Web |
American Roentgen Ray Society Images of Autoimmune polyendocrine syndrome classification |
Autoimmune polyendocrine syndrome classification in the news |
Directions to Hospitals Treating Autoimmune polyendocrine syndrome |
Risk calculators and risk factors for Autoimmune polyendocrine syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Classification
On the basis of organ involvement, autoimmune polyendocrine syndrome (APS) can be classified into APS type 1, APS type 2 and APS type 3
Autoimmune polyendocrine syndrome (APS) | |||||||||||||||||||||||||||||||||||
Autoimmune polyendocrine syndrome type 1 | Autoimmune polyendocrine syndrome type 2 | Autoimmune polyendocrine syndrome type 3 | |||||||||||||||||||||||||||||||||
•Mucocutaneous candidiasis •Hypoparathyroidism •Addison's disease | •Addison's disease •Autoimmune thyroiditis •Diabetes mellitus type 1 | •Autoimmune thyroiditis •Diabetes mellitus type 1 •Pernicious anemia | |||||||||||||||||||||||||||||||||
Autoimmune polyendocrine syndrome (APS) type 3 can be further classified into APS type 3A, APS type 3B and APS type 3C
Autoimmune polyendocrine syndrome type 3 | |||||||||||||||||||||||||||||||||||
Autoimmune polyendocrine syndrome type 3A | Autoimmune polyendocrine syndrome type 3B | Autoimmune polyendocrine syndrome type 3C | |||||||||||||||||||||||||||||||||
•Autoimmune thyroiditis •Immune mediated diabetes mellitus | •Autoimmune thyroiditis •Pernicious anemia | •Autoimmune thyroiditis •Vitiligo/Alopecia | |||||||||||||||||||||||||||||||||
Type 2
Autoimmune polyendocrine syndrome, type 2 also known as "Schmidt's syndrome". Features of this syndrome are:
- Addison's disease
- hypothyroidism
- diabetes mellitus (type 1)
- less common associations:
- hypogonadism
- vitiligo
Some researchers favour splitting this syndrome into three distinct syndromes (numbering 2, 3 and 4), but research evidence for these distinct combinations is not convincing.
XPID
The most serious but rarest form is the X-linked polyendocrinopathy, immunodeficiency and diarrhea-syndrome, also called IPEX. Most patients develop diabetes and diarrhea as neonates and many die due to autoimmune activity against many organs. Boys are affected, while girls are carriers and might suffer mild disease.
Other diseases
Other diseases featuring polyendocrine autoimmunity:
- Chromosomal abnormalities (Down's syndrome) increase the risk of endocrine autoimmunity
- POEMS syndrome - the E is for endocrinopathy; the cause is a paraprotein excreted by a plasmacytoma or multiple myeloma; other features are polyneuropathy, organomegaly (hepatomegaly and splenomegaly), M-protein (paraprotein) and skin changes.
- Several very rare diseases.
Classification
- There is no established system for the classification of [disease name].
OR
- [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
- [group1]
- [group2]
- [group3]
- [group4]
OR
- [Disease name] may be classified into [large number > 6] subtypes based on:
- [classification method 1]
- [classification method 2]
- [classification method 3]
- [Disease name] may be classified into several subtypes based on:
- [classification method 1]
- [classification method 2]
- [classification method 3]
OR
- Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
- If the staging system involves specific and characteristic findings and features:
- According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
- The staging of [malignancy name] is based on the [staging system].
OR
- There is no established system for the staging of [malignancy name].